Page last updated: 2024-10-24

carvedilol and Carcinoma, Hepatocellular

carvedilol has been researched along with Carcinoma, Hepatocellular in 2 studies

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"Collectively, in HA59T hepatoma cells, carvedilol induced [Ca2+]i rises by causing Ca2+ release from the endoplasmic reticulum in a phospholipase-C-independent manner and Ca2+ influx via store-operated Ca2+ channels."1.34Mechanisms of carvedilol-induced [Ca2+] i rises and death in human hepatoma cells. ( Cheng, JS; Chou, CT; Huang, CC; Jan, CR, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sinha, R1
Cheng, JS1
Huang, CC1
Chou, CT1
Jan, CR1

Other Studies

2 other studies available for carvedilol and Carcinoma, Hepatocellular

ArticleYear
Exploring the potential chemoprophylactic role of carvedilol for hepatocellular carcinoma.
    Clinical advances in hematology & oncology : H&O, 2022, Volume: 20, Issue:6

    Topics: Carcinoma, Hepatocellular; Carvedilol; Humans; Liver Neoplasms

2022
Mechanisms of carvedilol-induced [Ca2+] i rises and death in human hepatoma cells.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 376, Issue:3

    Topics: Adrenergic beta-Antagonists; Apoptosis; Calcium; Carbazoles; Carcinoma, Hepatocellular; Carvedilol;

2007